CDTX
Cidara Therapeutics
CDTX
CDTX
Delisted
CDTX was delisted on the 6th of January, 2026.
50 hedge funds and large institutions have $20.2M invested in Cidara Therapeutics in 2024 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 8 increasing their positions, 13 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more capital invested
Capital invested by funds: $ → $
more funds holding in top 10
Funds holding in top 10: →
less ownership
Funds ownership: →
less funds holding
Funds holding: →
13% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 8
38% less repeat investments, than reductions
Existing positions increased: 8 | Existing positions reduced: 13
Holders
50
Holding in Top 10
1
Calls
$11K
Puts
–
Top Buyers
| 1 | +$540K | |
| 2 | +$96.9K | |
| 3 | +$60.7K | |
| 4 |
TAM
Tocqueville Asset Management
New York
|
+$48.8K |
| 5 |
Two Sigma Investments
New York
|
+$48.3K |
Top Sellers
| 1 | -$1.23M | |
| 2 | -$160K | |
| 3 | -$100K | |
| 4 |
VF
Virtu Financial
New York
|
-$76K |
| 5 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$60.2K |